Tags

Type your tag names separated by a space and hit enter

Analysis and application of a suite of recombinant endo-β(1,3)-D-glucanases for studying fungal cell walls.
Microb Cell Fact. 2021 Jul 03; 20(1):126.MC

Abstract

BACKGROUND

The fungal cell wall is an essential and robust external structure that protects the cell from the environment. It is mainly composed of polysaccharides with different functions, some of which are necessary for cell integrity. Thus, the process of fractionation and analysis of cell wall polysaccharides is useful for studying the function and relevance of each polysaccharide, as well as for developing a variety of practical and commercial applications. This method can be used to study the mechanisms that regulate cell morphogenesis and integrity, giving rise to information that could be applied in the design of new antifungal drugs. Nonetheless, for this method to be reliable, the availability of trustworthy commercial recombinant cell wall degrading enzymes with non-contaminating activities is vital.

RESULTS

Here we examined the efficiency and reproducibility of 12 recombinant endo-β(1,3)-D-glucanases for specifically degrading the cell wall β(1,3)-D-glucan by using a fast and reliable protocol of fractionation and analysis of the fission yeast cell wall. This protocol combines enzymatic and chemical degradation to fractionate the cell wall into the four main polymers: galactomannoproteins, α-glucan, β(1,3)-D-glucan and β(1,6)-D-glucan. We found that the GH16 endo-β(1,3)-D-glucanase PfLam16A from Pyrococcus furiosus was able to completely and reproducibly degrade β(1,3)-D-glucan without causing the release of other polymers. The cell wall degradation caused by PfLam16A was similar to that of Quantazyme, a recombinant endo-β(1,3)-D-glucanase no longer commercially available. Moreover, other recombinant β(1,3)-D-glucanases caused either incomplete or excessive degradation, suggesting deficient access to the substrate or release of other polysaccharides.

CONCLUSIONS

The discovery of a reliable and efficient recombinant endo-β(1,3)-D-glucanase, capable of replacing the previously mentioned enzyme, will be useful for carrying out studies requiring the digestion of the fungal cell wall β(1,3)-D-glucan. This new commercial endo-β(1,3)-D-glucanase will allow the study of the cell wall composition under different conditions, along the cell cycle, in response to environmental changes or in cell wall mutants. Furthermore, this enzyme will also be greatly valuable for other practical and commercial applications such as genome research, chromosomes extraction, cell transformation, protoplast formation, cell fusion, cell disruption, industrial processes and studies of new antifungals that specifically target cell wall synthesis.

Authors+Show Affiliations

Instituto de Biología Funcional y Genómica Zacarías González, 2. CSIC and Universidad de Salamanca, 37007, Salamanca, Spain.Instituto de Biología Funcional y Genómica Zacarías González, 2. CSIC and Universidad de Salamanca, 37007, Salamanca, Spain.Instituto de Biología Funcional y Genómica Zacarías González, 2. CSIC and Universidad de Salamanca, 37007, Salamanca, Spain.Instituto de Biología Funcional y Genómica Zacarías González, 2. CSIC and Universidad de Salamanca, 37007, Salamanca, Spain.Instituto de Biología Funcional y Genómica Zacarías González, 2. CSIC and Universidad de Salamanca, 37007, Salamanca, Spain.Instituto de Biología Funcional y Genómica Zacarías González, 2. CSIC and Universidad de Salamanca, 37007, Salamanca, Spain. ribas@usal.es.Instituto de Biología Funcional y Genómica Zacarías González, 2. CSIC and Universidad de Salamanca, 37007, Salamanca, Spain. cortes@usal.es.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

34217291

Citation

Carvalho, Vanessa S D., et al. "Analysis and Application of a Suite of Recombinant endo-β(1,3)-D-glucanases for Studying Fungal Cell Walls." Microbial Cell Factories, vol. 20, no. 1, 2021, p. 126.
Carvalho VSD, Gómez-Delgado L, Curto MÁ, et al. Analysis and application of a suite of recombinant endo-β(1,3)-D-glucanases for studying fungal cell walls. Microb Cell Fact. 2021;20(1):126.
Carvalho, V. S. D., Gómez-Delgado, L., Curto, M. Á., Moreno, M. B., Pérez, P., Ribas, J. C., & Cortés, J. C. G. (2021). Analysis and application of a suite of recombinant endo-β(1,3)-D-glucanases for studying fungal cell walls. Microbial Cell Factories, 20(1), 126. https://doi.org/10.1186/s12934-021-01616-0
Carvalho VSD, et al. Analysis and Application of a Suite of Recombinant endo-β(1,3)-D-glucanases for Studying Fungal Cell Walls. Microb Cell Fact. 2021 Jul 3;20(1):126. PubMed PMID: 34217291.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Analysis and application of a suite of recombinant endo-β(1,3)-D-glucanases for studying fungal cell walls. AU - Carvalho,Vanessa S D, AU - Gómez-Delgado,Laura, AU - Curto,M Ángeles, AU - Moreno,M Belén, AU - Pérez,Pilar, AU - Ribas,Juan Carlos, AU - Cortés,Juan Carlos G, Y1 - 2021/07/03/ PY - 2021/05/03/received PY - 2021/06/19/accepted PY - 2021/7/4/entrez PY - 2021/7/5/pubmed PY - 2021/10/30/medline KW - Cell wall KW - Fission yeast KW - Fungi KW - Recombinant endo-β(1,3)-D-glucanase KW - β(1,3)-D-glucan SP - 126 EP - 126 JF - Microbial cell factories JO - Microb Cell Fact VL - 20 IS - 1 N2 - BACKGROUND: The fungal cell wall is an essential and robust external structure that protects the cell from the environment. It is mainly composed of polysaccharides with different functions, some of which are necessary for cell integrity. Thus, the process of fractionation and analysis of cell wall polysaccharides is useful for studying the function and relevance of each polysaccharide, as well as for developing a variety of practical and commercial applications. This method can be used to study the mechanisms that regulate cell morphogenesis and integrity, giving rise to information that could be applied in the design of new antifungal drugs. Nonetheless, for this method to be reliable, the availability of trustworthy commercial recombinant cell wall degrading enzymes with non-contaminating activities is vital. RESULTS: Here we examined the efficiency and reproducibility of 12 recombinant endo-β(1,3)-D-glucanases for specifically degrading the cell wall β(1,3)-D-glucan by using a fast and reliable protocol of fractionation and analysis of the fission yeast cell wall. This protocol combines enzymatic and chemical degradation to fractionate the cell wall into the four main polymers: galactomannoproteins, α-glucan, β(1,3)-D-glucan and β(1,6)-D-glucan. We found that the GH16 endo-β(1,3)-D-glucanase PfLam16A from Pyrococcus furiosus was able to completely and reproducibly degrade β(1,3)-D-glucan without causing the release of other polymers. The cell wall degradation caused by PfLam16A was similar to that of Quantazyme, a recombinant endo-β(1,3)-D-glucanase no longer commercially available. Moreover, other recombinant β(1,3)-D-glucanases caused either incomplete or excessive degradation, suggesting deficient access to the substrate or release of other polysaccharides. CONCLUSIONS: The discovery of a reliable and efficient recombinant endo-β(1,3)-D-glucanase, capable of replacing the previously mentioned enzyme, will be useful for carrying out studies requiring the digestion of the fungal cell wall β(1,3)-D-glucan. This new commercial endo-β(1,3)-D-glucanase will allow the study of the cell wall composition under different conditions, along the cell cycle, in response to environmental changes or in cell wall mutants. Furthermore, this enzyme will also be greatly valuable for other practical and commercial applications such as genome research, chromosomes extraction, cell transformation, protoplast formation, cell fusion, cell disruption, industrial processes and studies of new antifungals that specifically target cell wall synthesis. SN - 1475-2859 UR - https://www.unboundmedicine.com/medline/citation/34217291/Analysis_and_application_of_a_suite_of_recombinant_endo_β_13__D_glucanases_for_studying_fungal_cell_walls_ L2 - https://microbialcellfactories.biomedcentral.com/articles/10.1186/s12934-021-01616-0 DB - PRIME DP - Unbound Medicine ER -